rhenium liposome
Small moleculeexperimental
Clinical trial activity
5 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2015 (NCT01906385)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetRadiodepletion
radiodepletion
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- rhenium liposome
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07061626 | Phase 1 | Sep 30, 2025 | Cytori Therapeutics, Northwestern University |
| NCT07098806 | Phase 1 | Jul 2, 2025 | Cytori Therapeutics |
| NCT05460507 | Phase 1 | Jan 2, 2023 | Cytori Therapeutics, Plus Therapeutics |
| NCT05034497 | Phase 1 | Oct 9, 2021 | Cytori Therapeutics, Plus Therapeutics |
| NCT01906385 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2015 | University of Texas, San Antonio |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cytori Therapeutics | For profit | 4 | 4 | 1 | 2021 |
| Plus Therapeutics | For profit | 2 | 0 | 1 | 2021 |
| Northwestern University | Academic/Hospital | 1 | 0 | 1 | 2025 |
| University of Texas, San Antonio | Academic/Hospital | 1 | 1 | 1 | 2015 |
4 organizations
Page 1 / 1